BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PRKACA, MGC48865, 5566, ENSG00000072062, P17612, PKACA, MGC102831
4 results:

  • 1. Prognostic prediction of systemic immune-inflammation status for patients with colorectal cancer: a novel pyroptosis-related model.
    Hu J; Tian C; Zhao Y; Guo Y; Chen S
    World J Surg Oncol; 2022 Jul; 20(1):234. PubMed ID: 35836259
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Increasing Incidence of Colon cancer in the Young: Assessing the Tumor Biology.
    Nfonsam VN; Jecius H; Chen D; Omesiete PN; Ewongwo AN; Elquza E; Scott AJ; Jandova J
    J Am Coll Surg; 2019 Jul; 229(1):79-90. PubMed ID: 30995524
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring (SRM) and tissue microarray (TMA) analysis.
    Kume H; Muraoka S; Kuga T; Adachi J; Narumi R; Watanabe S; Kuwano M; Kodera Y; Matsushita K; Fukuoka J; Masuda T; Ishihama Y; Matsubara H; Nomura F; Tomonaga T
    Mol Cell Proteomics; 2014 Jun; 13(6):1471-84. PubMed ID: 24687888
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Selective modifications of cellular proteins in intratumoral subpopulations of human colonic carcinoma cells.
    Chakrabarty S; Miller CA; Brattain MG
    Cancer Invest; 1986; 4(1):5-14. PubMed ID: 3955419
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.